Proem Advisors’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.28M Buy
110,000
+65,000
+144% +$1.54M 0.14% 34
2025
Q4
$1.46M Sell
45,000
-40,000
-47% -$1.71M 0.17% 33
2025
Q3
$4.82M Sell
85,000
-374,977
-82% -$19.2M 0.51% 37
2025
Q2
$22.9M Hold
459,977
3.02% 10
2025
Q1
$13.6M Hold
459,977
4.08% 8
2024
Q4
$11.1M Buy
+459,977
New +$11.4M 2.96% 16

Other funds holding HIMS

Proem Advisors's HIMS Position: Q1 2026 in Review

Proem Advisors increased its Hims & Hers Health (HIMS) stake by 144% in Q1 2026, buying an estimated $1.54M and bringing the position to 110,000 shares worth $2.28M. The position accounts for 0.14% of the portfolio, ranked #34.

Proem Advisors first reported a position in HIMS in Q4 2024 and has held it in 6 quarters since. The position peaked at $22.9M in Q2 2025. 434 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.

  • Proem Advisors held 110,000 shares of Hims & Hers Health worth $2.28M as of Q1 2026.
  • Proem Advisors bought 65,000 Hims & Hers Health shares in Q1 2026, an estimated $1.54M.
  • Hims & Hers Health made up 0.14% of Proem Advisors's portfolio in Q1 2026, its #34 holding.
  • Proem Advisors first reported a position in Hims & Hers Health in Q4 2024 and has held it in 6 quarters since.
  • Proem Advisors's Hims & Hers Health position peaked at $22.9M in Q2 2025.
  • 434 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.

Based on Proem Advisors's 13F filing for Q1 2026, filed 13 May 2026.